Lv1
64 积分 2026-05-11 加入
Human CD36 deficiency is associated with elevation in low-density lipoprotein-cholesterol
1天前
已关闭
CD36 in Atherosclerosis: Pathophysiological Mechanisms and Therapeutic Implications
11天前
已完结
Efficacy and safety of ongericimab in Chinese statin-intolerant patients with primary hypercholesterolemia or mixed dyslipidemia: a randomized, placebo-controlled phase 3 trial
29天前
已完结
Lipid-lowering therapy with inclisiran in the real-world setting: Initial data from a national health care service
1个月前
已完结
Transformer-based models for predicting cardiovascular risk in Chinese adults: development and validation
2个月前
已完结
Meta-Analysis of Inclisiran for the Treatment of Hypercholesterolemia
2个月前
已完结
The Impact of Inclisiran on Lipid Profiles in Adults with Hyperlipidemia: A Meta-Analysis and Meta-Regression of Randomized Controlled Trials
2个月前
已完结
Lipoprotein(a) reduction with inclisiran, alirocumab, evolocumab, enlicitide, and lerodalcibep: A systematic review and meta-analysis of randomized controlled trials
2个月前
已完结
Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial
2个月前
已完结
What Inclisiran Monotherapy Teaches Us About LDL-C Regulation and CV Prevention
2个月前
已完结
皖公网安备34019202002308
